DrugNews Alert: Pradaxa Highest in Injury Reports to FDA

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
DrugNews added a report from the Institute for Safe Medication Practices that concluded Pradaxa had the highest number of side effect complaints to the FDA last year, with 683 reports of bleeding.

Chicago, IL (PRWEB) November 14, 2013

The drug safety center at DrugNews.net is new information on the site for patients taking the blood thinner Pradaxa. A recent medication safety report listed the drug highest for the number of side effects reported to the FDA last year*.

DrugNews gives those taking popular prescription drugs the latest information on recalls, safety alerts, research and litigation news. Patients can avoid dangerous meds, see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is an anticoagulant, or blood thinner, which was approved by the FDA in 2010. It is prescribed to patients with atrial fibrillation to prevent blood clots and stroke. While the FDA has stated Pradaxa is as safe as traditional blood thinner warfarin**, other experts disagree.

The Institute for Safe Medication Practices has warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from warfarin bleeding***. A study this year from the Netherlands also suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

Most recently, DrugNews added a report from the Institute for Safe Medication Practices that concluded Pradaxa had the highest number of side effect complaints to the FDA last year, with 683 reports of bleeding*.

With the number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The latest court records show as many as 1,643 cases filed as of October 17th*****.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Institute for Safe Medication Practices, 10/17/13; ismp.org/quarterwatch/pdfs/2012Q4.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf


Contact